A Brief History of Anti-VEGF for the Treatment of Ocular Angiogenesis
Year: 2012
Type: review
Abstract: In 1994, The American Journal of Pathology published a key article reporting that hypoxic retina produces vascular endothelial growth factor (VEGF), suggesting a role for VEGF in ocular neovascularization. Subsequent developments in anti-VEGF treatment for neovascular eye disease have improved visual outcomes and changed the standard of care in retinal medicine and ophthalmology.
Source: American Journal Of Pathology
Authors: Leo A. Kim, Patricia A. D'Amore
Institutions: Massachusetts Eye and Ear Infirmary, Harvard University
Language: English
Subfield: Ophthalmology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $2,800
Funder: National Eye Institute
OpenAlex ID: W2042978638
